BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36669639)

  • 1. Age affects the diagnostic accuracy of serum N-terminal pro-B-type natriuretic peptide for heart failure in patients with pleural effusion.
    Zhang M; Jiang MP; Yan L; Wen JX; Zheng WQ; Hu ZD
    Clin Biochem; 2023 Apr; 114():52-58. PubMed ID: 36669639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
    Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.
    Klemen P; Golub M; Grmec S
    Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion.
    Seyhan EC; Altin S; Cetinkaya E; Sokucu S; Gunluoglu MZ; Demir A; Korkmaz P; Issever H
    Intern Med; 2009; 48(5):287-93. PubMed ID: 19252349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NT-proBNP and lung ultrasound in diagnosing and classifying heart failure in a hospitalized oldest-old population: a cross-sectional study.
    Landolfo M; Spannella F; Giulietti F; Di Pentima C; Giordano P; Borioni E; Landi L; Di Rosa M; Galeazzi R; Sarzani R
    BMC Geriatr; 2024 Apr; 24(1):354. PubMed ID: 38643091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.
    Yeh JH; Huang CT; Liu CH; Ruan SY; Tsai YJ; Chien YC; Yang CY; Huang CK; Hsu CL; Kuo LC; Lee PL; Ku SC; Kuo PH; Yu CJ;
    PLoS One; 2014; 9(12):e115301. PubMed ID: 25502236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
    Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
    Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis.
    Zhou Q; Ye ZJ; Su Y; Zhang JC; Shi HZ
    Heart; 2010 Aug; 96(15):1207-11. PubMed ID: 20511623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.
    Long AC; O'Neal HR; Peng S; Lane KB; Light RW
    Chest; 2010 Jun; 137(6):1369-74. PubMed ID: 20139229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
    Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
    Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.
    Porcel JM; Chorda J; Cao G; Esquerda A; Ruiz-González A; Vives M
    Respirology; 2007 Sep; 12(5):654-9. PubMed ID: 17875051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
    Han CH; Choi JE; Chung JH
    Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study.
    Røsjø H; Dahl MB; Jørgensen M; Røysland R; Brynildsen J; Cataliotti A; Christensen G; Høiseth AD; Hagve TA; Omland T
    Clin Chem; 2015 Aug; 61(8):1087-97. PubMed ID: 26056354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Chen AA; Tung R; Anwaruddin S; Baggish AL; Januzzi JL
    J Card Fail; 2006 Aug; 12(6):452-7. PubMed ID: 16911912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.
    Wurtinger G; Henrich E; Hildebrandt N; Wiedemann N; Schneider M; Hassdenteufel E
    BMC Vet Res; 2017 Dec; 13(1):394. PubMed ID: 29262821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
    Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
    ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.